Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Systemic inflammation in ALSP before and after allogeneic hematopoietic stem cell transplantation
NL-OMON49611Recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Feb 2021
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Open-label trial of allogeneic hematopoietic stem cell transplantation in CSF1R-related leukoencephalopathy (ALSP) (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoints: Baseline blood cytokine profile before HCT and Longitudinal blood cytokine profile after HCT. Started Feb 2021; status: recruiting.
02
Drugs
allogeneic hematopoietic stem cell transplantation
03
Conditions
CSF1R-related leukoencephalopathy (ALSP)
Beyond the preview
Go deeper on NL-OMON49611.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON49611.